Call:+1 7755157689
February 23, 2025


Contact Us

Issue 10

Neoadjuvant therapy for HER-2 positive acantholytic squamous cell carcinoma of the breast: a case report

HER2-positive breast ASCC is exceptionally rare, its clinico pathological characteristics are insufficiently studied, and the im plications of neoadjuvant therapy, comprising targeted treatment against HER2. Here we reported that a 58-year-old woman with a histopathological diagnosis of HER2-positive ASCC gave a neo adjuvant therapy of albumin-paclitaxel, carboplatin in conjunction with trastuzumab every 3 weeks.

Neoadjuvant therapy for HER-2 positive acantholytic squamous cell carcinoma of the breast: a case report Read More »

Viral load and antibody responses in an asymptomatic/minimally symptomatic SARS-CoV2 positive cohort in Sri Lanka

Asymptomatic patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are silent carriers of the disease. We aimed to characterize their dynamics of disease occurrence, viral shedding and antibody responses using a cohort of asymptomatic/ minimally symptomatic patients from Sri Lanka during the first wave of COVID-19.

Viral load and antibody responses in an asymptomatic/minimally symptomatic SARS-CoV2 positive cohort in Sri Lanka Read More »

You cannot copy content of this page